He and the other two hundred and ten passengers on Singapore Airlines Flight SQ321 had been in the air for more than ten hours. Their flight had taken off the night before from the United Kingdom, ...

Every time Agnes publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Fifty-four seconds. That’s how long it took Raphael Wimmer to write up an experiment that he did not actually perform, using a new artificial-intelligence tool called Prism, released by OpenAI last ...

Super Micro Computer (SMCI) dropped 11% this week despite crushing earnings on February 3rd. Wall Street focused this week on margin pressures, which led to more pressure on shares. Goldman Sachs ...

A sweeping new review of ADHD treatments—drawing on more than 200 meta-analyses—cuts through years of mixed messaging and hype. To make sense of it all, researchers have launched an interactive, ...

The UK government is launching a call for evidence on how technology, changing market dynamics and regulation are shaping investment in mobile networks. The call for evidence was introduced as an ...

Last summer GEEKOM released a pair of mini PCs with the latest Intel and AMD processors: the GEEKOM IT15 with an Intel Core Ultra 9 285H Arrow Lake processor and the GEEKOM A9 Max with an AMD Ryzen AI ...

This study used pupillometry to provide an objective assessment of a form of synesthesia in which people see additional color when reading numbers. It provides convincing evidence that subjective ...

The Renpho Morphoscan Nova delivers in-depth body composition analysis and useful weight management insights in a light, height-inclusive package. However, its temperamental app connectivity and ...

A simple brain-training program that sharpens how quickly older adults process visual information may have a surprisingly powerful long-term payoff. In a major 20-year study of adults 65 and older, ...

From cabbies to the Czech Republic ...

SYDNEY, March 10, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that ...